Sfoglia per AUTORE
BUGIANESI E
Collezione AOU Città della Salute di Torino

  

Items : 87

2025
AOU Città della Salute di Torino

Liu WY; Huang S; Ji H; Kim SU; Cheuk-Fung Yip T; Lai-Hung Wong G; Petta S; Tsochatzis E; Nakajima A; Bugianesi E; George Goh BB; Chan WK; Romero-Gomez M; Sanyal AJ; Boursier J; Hagström H; Calleja JL; de Lédinghen V; Newsome PN; Fan JG; Lai M; Castéra L; Lee HW; Pennisi G; Yoneda M; Armandi A; Kim-Jun Teh K; Gallego-Durán R; Asgharpour A; et alii...

Prognostic performance of the two-step clinical care pathway in metabolic dysfunction-associated steatotic liver disease. in Journal of hepatology / J Hepatol. 2025 Jan 23:S0168-8278(25)00021-2. doi: 10.1016/j.jhep.2025.01.014.
2025
AOU Città della Salute di Torino

Yip TC; Lee HW; Lin H; Tsochatzis E; Petta S; Bugianesi E; Yoneda M; Zheng MH; Hagström H; Boursier J; Calleja JL; Goh GB; Chan WK; Gallego-Durán R; Sanyal AJ; de Lédinghen V; Newsome PN; Fan JG; Castéra L; Lai M; Fournier-Poizat C; Wong GL; Pennisi G; Armandi A; Nakajima A; Liu WY; Shang Y; de Saint-Loup M; Llop E; et alii...

Precision in Liver Diagnosis: Varied Accuracy Across Subgroups and the Need for Variable Thresholds in Diagnosis of MASLD. in Liver international : official journal of the International Association for the Study of the Liver / Liver Int. 2025 Feb;45(2):e16240. doi: 10.1111/liv.16240.
2025
AOU Città della Salute di Torino

Vali Y; van Dijk AM; Lee J; Boursier J; Ratziu V; Yunis C; Schattenberg JM; Valenti L; Gomez MR; Schuppan D; Petta S; Allison M; Hartman ML; Porthan K; Dufour JF; Bugianesi E; Gastadelli A; Derdak Z; Fournier-Poizat C; Shumbayawonda E; Kalutkiewicz M; Yki-Jarvinen H; Ekstedt M; Geier A; Trylesinski A; Francque S; Brass C; Pavlides M; Holleboom AG; et alii...

acFibroMASH Index for the Diagnosis of Fibrotic MASH and Prediction of Liver-related Events: An International Multicenter Study. in Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association / Clin Gastroenterol Hepatol. 2025 Apr;23(5):785-796. doi: 10.1016/j.cgh.2024.07.045. Epub 2024 Oct 2.
2025
AOU Città della Salute di Torino

Chan MS; Canivet CM; Mahgoub S; Asgharpour A; Lara-Romero C; Teh KKJ; Llop E; Shang Y; de Saint-Loup M; Armandi A; Liu WY; Pennisi G; Fournier-Poizat C; Wong GL; Yip TC; Lee HW; Lin H; Yang S; Wang J; Li L; Zeng QL; Ye Q; Deng H; Liu C; Zhou Y; Yan X; Niu J; Lu Z; Nan Y; et alii...

Increased prevalence of high-risk coronary plaques in metabolic dysfunction associated steatotic liver disease patients: A meta-analysis. in European journal of clinical investigation / Eur J Clin Invest. 2024 Sep;54(9):e14188. doi: 10.1111/eci.14188. Epub 2024 Feb 23.
2024
ASL Città di Torino
AOU Città della Salute di Torino

De Ferrari GM; D'Ascenzo F; Iannaccone M; Bugianesi E; Mennini G; Corradini SG; Mancone M; Zullino V; Bruno F; Gallone G; Armandi A; Birtolo LI; Nebiolo M; Gatti M; Ribaldone DG; De Filippo O; Di Pietro G;

Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease. in Gut / Gut. 2024 Oct 7;73(11):1883-1892. doi: 10.1136/gutjnl-2024-333074.
2024
AOU Città della Salute di Torino

Zhou XD; Kim SU; Yip TC; Petta S; Nakajima A; Tsochatzis E; Boursier J; Bugianesi E; Hagström H; Chan WK; Romero-Gomez M; Calleja JL; de Lédinghen V; Castéra L; Sanyal AJ; Goh GB; Newsome PN; Fan J; Lai M; Fournier-Poizat C; Lee HW; Wong GL; Armandi A; Shang Y; Pennisi G; Llop E; Yoneda M; Saint-Loup M; Canivet CM; et alii...

Hepatic glucose production rises with the histological severity of metabolic dysfunction-associated steatohepatitis. in Cell reports. Medicine / Cell Rep Med. 2024 Nov 19;5(11):101820. doi: 10.1016/j.xcrm.2024.101820.
2024
AOU Città della Salute di Torino

Sabatini S; Sen P; Carli F; Pezzica S; Rosso C; Lembo E; Verrastro O; Daly A; Govaere O; Cockell S; Hyötyläinen T; Mingrone G; Bugianesi E; Anstee QM; Oreši? M; Gastaldelli A;

Helicobacter pylori in Inflammatory Bowel Diseases: Active Protagonist or Innocent Bystander? in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2024 Mar 17;13(3):267. doi: 10.3390/antibiotics13030267.
2024
AOU Città della Salute di Torino

Bretto E; Frara S; Armandi A; Caviglia GP; Saracco GM; Bugianesi E; Pitoni D; Ribaldone DG;

Evaluation of Google Search Trends for Liver Diseases in Europe. in Journal of gastrointestinal and liver diseases : JGLD / J Gastrointestin Liver Dis. 2024 Jun 29;33(2):234-244. doi: 10.15403/jgld-5477.
2024
AOU Città della Salute di Torino

Teufel A; Itzel T; Zimmermann A; Dumitrascu D; Bugianesi E; Valenti L; Castera L; Carrieri P; Crespo J; Romero-Gomez M; Flisiak R; Krawczyk M; Ebert M; Lazarus JV; Tacke F;

2024
AOU Città della Salute di Torino

Castelnuovo G; Perez-Diaz-Del-Campo N; Rosso C; Armandi A; Caviglia GP; Bugianesi E;

A prospective, multicenter, three-cohort study evaluating contrast-induced acute kidney injury (CI-AKI) in patients with cirrhosis. in Journal of hepatology / J Hepatol. 2024 Jan;80(1):62-72. doi: 10.1016/j.jhep.2023.10.010. Epub 2023 Oct 20.
2024
AOU Città della Salute di Torino

Manca A; Saracco GM; Marzano A; Mengozzi G; Bugianesi E; Martini S; Rizzo M; Giovo I; Bonetto S; Frigo F; Sanavia T; Caviglia GP; Caropreso P; Risso A; Campion D; Ponzo P; Alessandria C;

Long-term follow-up of web-based and group-based behavioural intervention in NAFLD in a real world clinical setting. in Alimentary pharmacology & therapeutics / Aliment Pharmacol Ther. 2024 Jan;59(2):249-259. doi: 10.1111/apt.17768. Epub 2023 Oct 16.
2024
AOU Città della Salute di Torino

Bugianesi E; Bertini F; Montesi D; Armandi A; Colosimo S; Brodosi L; Petroni ML; Marchesini G;

Prebiotics targeting gut-liver axis to treat non-alcoholic fatty liver disease. in Minerva gastroenterology / Minerva Gastroenterol (Torino). 2024 Dec;70(4):446-453. doi: 10.23736/S2724-5985.23.03361-2. Epub 20
2024
AOU Città della Salute di Torino

Caviglia GP; Rosso C; Armandi A; Guariglia M; Poggiolini I; Perez-Diaz-Del-Campo N; Castelnuovo G; Bugianesi E;

2024
AOU Città della Salute di Torino

Armandi A; Sanavia T; Younes R; Caviglia GP; Rosso C; Govaere O; Liguori A; Francione P; Gallego-Duràn R; Ampuero J; Pennisi G; Aller R; Tiniakos D; Burt A; David E; Vecchio F; Maggioni M; Cabibi D; McLeod D; Pareja MJ; Zaki MYW; Grieco A; Stål P; Kechagias S; Fracanzani AL; Valenti L; Miele L; Fariselli P; Eslam M; et alii...

Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease. in JAMA / JAMA. 2024 Apr 16;331(15):1287-1297. doi: 10.1001/jama.2024.1447.
2024
AOU Città della Salute di Torino

Lin H; Lee HW; Yip TC; Tsochatzis E; Petta S; Bugianesi E; Yoneda M; Zheng MH; Hagström H; Boursier J; Calleja JL; Goh GB; Chan WK; Gallego-Durán R; Sanyal AJ; de Lédinghen V; Newsome PN; Fan JG; Castéra L; Lai M; Harrison SA; Fournier-Poizat C; Wong GL; Pennisi G; Armandi A; Nakajima A; Liu WY; Shang Y; de Saint-Loup M; et alii...

Non-Alcoholic Steatohepatitis Patient Characterization and Real-World Management Approaches in Italy. in Pragmatic and observational research / Pragmat Obs Res. 2024 Oct 10;15:185-200. doi: 10.2147/POR.S472468. eCollection 2024.
2024
AOU Città della Salute di Torino

Grau K; Mancuso M; Donnarumma G; Miele L; Bugianesi E; Prasad P; Leith A; Higgins V;

Nutrition could prevent or promote non-alcoholic fatty liver disease: an opportunity for intervention. in BMJ (Clinical research ed.) / BMJ. 2023 Oct 9;383:e075179. doi: 10.1136/bmj-2023-075179.
2023
AOU Città della Salute di Torino

Romero-Gómez M; Zelber-Sagi S; Martín F; Bugianesi E; Soria B;

A nutrigenetic precision approach for the management of non-alcoholic fatty liver disease. in Clinical nutrition (Edinburgh, Scotland) / Clin Nutr. 2023 Nov;42(11):2181-2187. doi: 10.1016/j.clnu.2023.09.022. Epub 2023 Sep 25.
2023
AOU Città della Salute di Torino

Armandi A; Rosso C; Caviglia GP; Guariglia M; Castelnuovo G; Nicolosi A; Perez-Diaz-Del-Campo N; Dileo E; Bugianesi E;

Patients with inflammatory bowel disease are at increased risk of atherothrombotic disease: A systematic review with meta-analysis. in International journal of cardiology / Int J Cardiol. 2023 May 1;378:96-104. doi: 10.1016/j.ijcard.2023.02.042. Epub 2023 Mar 1.
2023
ASL Città di Torino
AOU Città della Salute di Torino

Ribaldone DG; Bugianesi E; Armandi A; De Ferrari GM; Bernstein CN; Caviglia GP; Giannino G; Testa G; De Filippo O; Bruno F; Iannaccone M; D'Ascenzo F;

Corrigendum to: "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort(?)" [J Hepatol (2020) 505-515]. in Journal of hepatology / J Hepatol. 2023 May;78(5):1085-1086. doi: 10.1016/j.jhep.2023.02.028. Epub 2023 Mar 13.
2023
AOU Città della Salute di Torino

Schattenberg JM; Valenti L; Ratziu V; Clement K; Bugianesi E; Petta S; Kechagias S; Francque S; Ekstedt M; Prati D; Invernizzi P; Dufour JF; Vacca M; Yki-Järvinen H; Allison M; Aithal GP; Liu YL; Palmer J; Bedossa P; Burt AD; Tiniakos D; Govaere O; Cockell S; Meroni M; Darlay R; Anstee QM; Day CP; Cordell HJ; Daly AK; et alii...

2023
AOU Città della Salute di Torino

Castelnuovo G; Perez-Diaz-Del-Campo N; Rosso C; Guariglia M; Armandi A; Nicolosi A; Caviglia GP; Bugianesi E;

Impact of Health Related QoL and Mediterranean Diet on Liver Fibrosis in Patients with NAFLD. in Nutrients / Nutrients. 2023 Jul 2;15(13):3018. doi: 10.3390/nu15133018.
2023
AOU Città della Salute di Torino

Perez-Diaz-Del-Campo N; Castelnuovo G; Rosso C; Nicolosi A; Guariglia M; Dileo E; Armandi A; Caviglia GP; Bugianesi E;

Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation study. in Hepatology (Baltimore, Md.) / Hepatology. 2023 Jul 1;78(1):258-271. doi: 10.1097/HEP.0000000000000364. Epub 2023 Mar 31.
2023
AOU Città della Salute di Torino

Schuppan D; Schattenberg JM; Yunis C; Karsdal M; Torstenson R; Romero-Gomez M; Aithal GP; Bugianesi E; Ekstedt M; Crespo J; Yki-Järvinen H; Holleboom AG; Cobbold J; Leeming DJ; Harrison S; Dufour JF; Pais R; Cortez-Pinto H; Papatheodoridis G; Allison M; Bedossa P; Tiniakos D; Wonders K; Francque S; Geier A; Fournier C; Alexander L; Chen Y; Ostroff R; et alii...

2023
AOU Città della Salute di Torino
AOU Novara

Bugianesi E; Saracco GM; Minisini R; Olivero A; Armandi A; Rosso C; Musso EC; Crevola M; Albè A; Burlone ME; Risso A; Rolle E; Carucci P; Troshina G; Abate ML; Caviglia GP; Pirisi M; Ciancio A; Gaia S;

Cross-Sectional and Longitudinal Performance of Non-Invasive Tests of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease. in Journal of clinical medicine / J Clin Med. 2023 Jan 13;12(2):650. doi: 10.3390/jcm12020650.
2023
AOU Città della Salute di Torino

Armandi A; Rosso C; Younes R; Leeming DJ; Karsdal MA; Caviglia GP; Pérez-Diaz-Del-Campo N; D'Amato D; Abdulle A; Nicolosi A; Castelnuovo G; Saracco GM; Ribaldone DG; Bugianesi E;

Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practice. in JHEP reports : innovation in hepatology / JHEP Rep. 2022 Sep 22;5(1):100596. doi: 10.1016/j.jhepr.2022.100596. eCollection 2023 Jan.
2023
AOU Città della Salute di Torino

Wong VW; Thiele M; Valenti L; Schattenberg JM; Romero-Gómez M; Loomba R; Hagström H; Cusi K; Colombo M; Bugianesi E; Alqahtani SA; Arrese M; Anstee QM; Adams LA; Allen AM; Mark HE; Castera L; Lazarus JV; Yilmaz Y; Younossi ZM; Francque SM; Tsochatzis EA;

2023
AOU Città della Salute di Torino

Petroni ML; Brodosi L; Armandi A; Marchignoli F; Bugianesi E; Marchesini G;

Inflammatory Bowel Disease: Emerging Therapies and Future Treatment Strategies. in Biomedicines / Biomedicines. 2023 Aug 11;11(8):2249. doi: 10.3390/biomedicines11082249.
2023
AOU Città della Salute di Torino

Bretto E; Ribaldone DG; Caviglia GP; Saracco GM; Bugianesi E; Frara S;

Quantitative modeling of human liver reveals dysregulation of glycosphingolipid pathways in nonalcoholic fatty liver disease. in iScience / iScience. 2022 Aug 15;25(9):104949. doi: 10.1016/j.isci.2022.104949. eCollection 2022 Sep 16.
2022
AOU Città della Salute di Torino

Sen P; Govaere O; Sinioja T; McGlinchey A; Geng D; Ratziu V; Bugianesi E; Schattenberg JM; Vidal-Puig A; Allison M; Cockell S; Daly AK; Hyötyläinen T; Anstee QM; Oreši? M;

Rare ATG7 genetic variants predispose patients to severe fatty liver disease. in Journal of hepatology / J Hepatol. 2022 Sep;77(3):596-606. doi: 10.1016/j.jhep.2022.03.031. Epub 2022 Apr 9.
2022
AOU Città della Salute di Torino

Prati D; Romeo S; Soardo G; Reeves HL; Fracanzani AL; Bugianesi E; Pihlajamaki J; Federico A; Vespasiani-Gentilucci U; Petta S; Miele L; Vaira V; D'Ambrosio R; Mancina RM; Cespiati A; Tavaglione F; Bianco C; Dongiovanni P; Maggioni M; Santoro L; Cherubini A; Malvestiti F; Saracino M; Ciociola E; Pelusi S; Baselli GA; Jamialahmadi O; Valenti LV;

Expression of SARS-Cov-2 Entry Factors in Patients with Chronic Hepatitis. in Viruses / Viruses. 2022 Oct 29;14(11):2397. doi: 10.3390/v14112397.
2022
AOU Città della Salute di Torino

Rosso C; Demelas C; Agostini G; Abate ML; Vernero M; Caviglia GP; D'Amato D; Armandi A; Tapparo M; Guariglia M; Troshina G; Massano A; Olivero A; Nicolosi A; Zannetti A; Pellicano R; Ciancio A; Saracco GM; Ribaldone DG; Bugianesi E; Fagoonee S;

Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight. in Nature reviews. Gastroenterology & hepatology / Nat Rev Gastroenterol Hepatol. 2022 Oct;19(10):638-651. doi: 10.1038/s41575-022-00635-5. Epub 2022 J
2022
AOU Città della Salute di Torino

Bugianesi E; Wei L; Sarin SK; Francque S; El-Serag HB; Eslam M; George J;

Role of Circadian Clock on the Pathogenesis and Lifestyle Management in Non-Alcoholic Fatty Liver Disease. in Nutrients / Nutrients. 2022 Nov 27;14(23):5053. doi: 10.3390/nu14235053.
2022
AOU Città della Salute di Torino

Perez-Diaz-Del-Campo N; Castelnuovo G; Caviglia GP; Armandi A; Rosso C; Bugianesi E;

Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease. in JHEP reports : innovation in hepatology / JHEP Rep. 2022 Mar 26;4(5):100477. doi: 10.1016/j.jhepr.2022.100477. eCollection 2022 May.
2022
AOU Città della Salute di Torino

Hyötyläinen T; Daly AK; Schattenberg JM; Bugianesi E; de Oliviera C; Petta S; Bousier J; Allison M; Ratziu V; Geng D; McGlinchey AJ; Govaere O; Anstee QM; Oreši? M;

Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis. in The Journal of pathology / J Pathol. 2022 May;257(1):82-95. doi: 10.1002/path.5871. Epub 2022 Mar 7.
2022
AOU Città della Salute di Torino

Bugianesi E; Pontisso P; Biasiolo A; Rosso C; Gaia S; Carucci P; Colombatto S; Bussolino F; Autelli R; Alvaro M; Novo E; Sutti S; Maggiora M; Turato C; Napione L; Di Maira G; Foglia B; Albano E; Marra F; Parola M; Cannito S;

Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease. in Journal of hepatology / J Hepatol. 2022 May;76(5):1001-1012. doi: 10.1016/j.jhep.2021.12.012. Epub 2021 Dec 21.
2022
AOU Città della Salute di Torino

Govaere O; Petersen SK; Martinez-Lopez N; Wouters J; Van Haele M; Mancina RM; Jamialahmadi O; Bilkei-Gorzo O; Lassen PB; Darlay R; Peltier J; Palmer JM; Younes R; Tiniakos D; Aithal GP; Allison M; Vacca M; Göransson M; Berlinguer-Palmini R; Clark JE; Drinnan MJ; Yki-Järvinen H; Dufour JF; Ekstedt M; Francque S; Petta S; Bugianesi E; Schattenberg JM; Day CP; et alii...

Clinical Application of Droplet Digital PCR for Hepatitis Delta Virus Quantification. in Biomedicines / Biomedicines. 2022 Mar 29;10(4):792. doi: 10.3390/biomedicines10040792.
2022
AOU Città della Salute di Torino

Olivero A; Rosso C; Ciancio A; Abate ML; Nicolosi A; Troshina G; Armandi A; Ribaldone DG; Saracco GM; Bugianesi E; Rizzetto M; Caviglia GP;

2022
AOU Città della Salute di Torino

Caviglia GP; Nicolosi A; Abate ML; Carucci P; Rosso C; Rolle E; Armandi A; Aneli S; Olivero A; Risso A; Ribaldone DG; Fermer C; Saracco GM; Gaia S; Bugianesi E;

2022
AOU Città della Salute di Torino

Armandi A; Rosso C; Nicolosi A; Caviglia GP; Abate ML; Olivero A; D'Amato D; Vernero M; Gaggini M; Saracco GM; Ribaldone DG; Leeming DJ; Gastaldelli A; Bugianesi E;

2022
AOU Città della Salute di Torino

Valenti L; Eslam M; Fariselli P; Birolo G; Grieco A; Pennisi G; Francione P; Liguori A; Zaki MYW; Caviglia GP; Armandi A; Gallego-Durán R; Rosso C; Ampuero J; Fracanzani AL; Aller R; Pareja MJ; McLeod D; Maggioni M; Cabibi D; David E; Vecchio FM; Burt A; Tiniakos D; Miele L; Govaere O; Petta S; Younes R; George J; et alii...

Serum glypican-3 for the prediction of survival in patients with hepatocellular carcinoma. in Minerva gastroenterology / Minerva Gastroenterol (Torino). 2022 Dec;68(4):378-386. doi: 10.23736/S2724-5985.21.03006-0. Epub 20
2022
AOU Città della Salute di Torino

Saracco GM; Pellicano R; Fagoonee S; Carucci P; Ribaldone DG; Armandi A; Olivero A; Abate ML; Rolle E; Rosso C; Risso A; Gaia S; Nicolosi A; Bugianesi E; Caviglia GP;

2022
AOU Città della Salute di Torino

Armandi A; Rosso C; Troshina G; Pérez Diaz Del Campo N; Marinoni C; Nicolosi A; Caviglia GP; Saracco GM; Bugianesi E; Ciancio A;

NAFLD/NASH. in Journal of hepatology / J Hepatol. 2022 Aug;77(2):549-550. doi: 10.1016/j.jhep.2022.02.006. Epub 2022 May 3.
2022
AOU Città della Salute di Torino

Petta S; Bugianesi E;

Derivation and validation of the nonalcoholic fatty liver disease cirrhosis score (NCS) to distinguish bridging fibrosis from cirrhosis. in European journal of internal medicine / Eur J Intern Med. 2022 Apr;98:53-60. doi: 10.1016/j.ejim.2021.12.011. Epub 2022 Jan 17.
2022
AOU Città della Salute di Torino

Schattenberg JM; Anstee QM; Bugianesi E; Gómez MR; Armandi A; Ampuero J; Galle PR; Myers RP; Ding D; Toenges G; Zheng MH; Labenz C;

Outcomes and potential surrogate markers for future clinical trials of non-alcoholic steatohepatitis cirrhosis. in Liver international : official journal of the International Association for the Study of the Liver / Liver Int. 2021 Sep;41(9):1999-2008. doi: 10.1111/liv.15013. Epub 2021 Jul 21.
2021
AOU Città della Salute di Torino

Bugianesi E; Armandi A; Augustin S; Rivera-Esteban J;

2021
AOU Città della Salute di Torino

Caviglia GP; De Blasio F; Vernero M; Armandi A; Rosso C; Saracco GM; Bugianesi E; Astegiano M; Ribaldone DG;

Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease. in Journal of hepatology / J Hepatol. 2021 Oct;75(4):786-794. doi: 10.1016/j.jhep.2021.05.008. Epub 2021 Jun 4.
2021
AOU Città della Salute di Torino

Petta S; Romero-Gomez M; Fariselli P; Miele L; Valenti L; Fracanzani AL; Grieco A; Zaki MYW; Pareja MJ; Cabibi D; Maggioni M; Vecchio FM; David E; Burt A; Tiniakos D; Aller R; Ampuero J; Garcia Blanco MJ; Gallego-Durán R; Francione P; Pennisi G; Liguori A; Sanavia T; Armandi A; Rosso C; Caviglia GP; Govaere O; Younes R; Anstee QM; et alii...

2021
AOU Città della Salute di Torino

Caviglia GP; Armandi A; Rosso C; Gaia S; Aneli S; Rolle E; Abate ML; Olivero A; Nicolosi A; Guariglia M; Ribaldone DG; Carucci P; Saracco GM; Bugianesi E;

Corrigendum to: "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort"? (J Hepatol [2020] 505-515). in Journal of hepatology / J Hepatol. 2021 May;74(5):1274-1275. doi: 10.1016/j.jhep.2021.02.003. Epub 2021 Mar 5.
2021
AOU Città della Salute di Torino

Anstee QM; Darlay R; Cockell S; Meroni M; Govaere O; Tiniakos D; Burt AD; Bedossa P; Palmer J; Liu YL; Aithal GP; Allison M; Yki-Järvinen H; Vacca M; Dufour JF; Invernizzi P; Prati D; Ekstedt M; Kechagias S; Francque S; Petta S; Bugianesi E; Clement K; Ratziu V; Schattenberg JM; Valenti L; Day CP; Cordell HJ; Daly AK; et alii...

2021
AOU Città della Salute di Torino

Caviglia GP; Abate ML; Rolle E; Carucci P; Armandi A; Rosso C; Olivero A; Ribaldone DG; Tandoi F; Saracco GM; Ciancio A; Bugianesi E; Gaia S;

Natural history of NASH. in Liver international : official journal of the International Association for the Study of the Liver / Liver Int. 2021 Jun;41 Suppl 1(Suppl 1):78-82. doi: 10.1111/liv.14910.
2021
AOU Città della Salute di Torino

Armandi A; Bugianesi E;

Switching from Biosimilar to Biosimilar Adalimumab, Including Multiple Switching, in Crohn's Disease: A Prospective Study. in Journal of clinical medicine / J Clin Med. 2021 Jul 30;10(15):3387. doi: 10.3390/jcm10153387.
2021
AOU Città della Salute di Torino

Ribaldone DG; Tribocco E; Rosso C; Armandi A; Vernero M; Bugianesi E; Astegiano M; Saracco GM; Caviglia GP;

Risk Factors of Urothelial Cancer in Inflammatory Bowel Disease. in Journal of clinical medicine / J Clin Med. 2021 Jul 23;10(15):3257. doi: 10.3390/jcm10153257.
2021
AOU Città della Salute di Torino

Caviglia GP; Martini G; Armandi A; Rosso C; Vernero M; Bugianesi E; Astegiano M; Saracco GM; Ribaldone DG;

Inflammatory Bowel Disease Nurse-Practical Messages. in Nursing reports (Pavia, Italy) / Nurs Rep. 2021 Apr 1;11(2):229-241. doi: 10.3390/nursrep11020023.
2021
AOU Città della Salute di Torino

Rosso C; Aaron AA; Armandi A; Caviglia GP; Vernero M; Saracco GM; Astegiano M; Bugianesi E; Ribaldone DG;

Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores. in Journal of hepatology / J Hepatol. 2021 Apr;74(4):775-782. doi: 10.1016/j.jhep.2020.11.024. Epub 2020 Nov 25.
2021
AOU Città della Salute di Torino

Prati D; Reeves H; Soardo G; Fracanzani AL; Berg T; Hampe J; Fischer J; Stickel F; Anstee QM; Vespasiani-Gentilucci U; Miele L; Petta S; Bugianesi E; Federico A; Alisi A; D'Ambrosio R; Spagnuolo R; Borroni V; Meroni M; Liguori A; Maier S; Zanoni I; Santoro L; Dongiovanni P; Baselli G; Pelusi S; Bianco C; Jamialahmadi O; Romeo S; et alii...

NASH limits anti-tumour surveillance in immunotherapy-treated HCC. in Nature / Nature. 2021 Apr;592(7854):450-456. doi: 10.1038/s41586-021-03362-0. Epub 2021 Mar 24.
2021
AOU Città della Salute di Torino

Pfister D; Núñez NG; Pinyol R; Govaere O; Pinter M; Szydlowska M; Gupta R; Qiu M; Deczkowska A; Weiner A; Müller F; Sinha A; Friebel E; Engleitner T; Lenggenhager D; Moncsek A; Heide D; Stirm K; Kosla J; Kotsiliti E; Leone V; Dudek M; Yousuf S; Inverso D; Singh I; Teijeiro A; Castet F; Montironi C; Haber PK; et alii...

The Impact of Dysmetabolic Sarcopenia Among Insulin Sensitive Tissues: A Narrative Review. in Frontiers in endocrinology / Front Endocrinol (Lausanne). 2021 Nov 10;12:716533. doi: 10.3389/fendo.2021.716533. eCollection 2021
2021
AOU Città della Salute di Torino

Bugianesi E; Ribaldone DG; Caviglia GP; Rosso C; Armandi A;

Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular Carcinoma. in Cancers / Cancers (Basel). 2020 Sep 28;12(10):2776. doi: 10.3390/cancers12102776.
2020
AOU Città della Salute di Torino

Caviglia GP; Ciruolo M; Olivero A; Carucci P; Rolle E; Rosso C; Abate ML; Risso A; Ribaldone DG; Tandoi F; Saracco GM; Bugianesi E; Gaia S;

Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort(?). in Journal of hepatology / J Hepatol. 2020 Sep;73(3):505-515. doi: 10.1016/j.jhep.2020.04.003. Epub 2020 Apr 13.
2020
AOU Città della Salute di Torino

Anstee QM; Darlay R; Cockell S; Meroni M; Govaere O; Tiniakos D; Burt AD; Bedossa P; Palmer J; Liu YL; Aithal GP; Allison M; Yki-Järvinen H; Vacca M; Dufour JF; Invernizzi P; Prati D; Ekstedt M; Kechagias S; Francque S; Petta S; Bugianesi E; Clement K; Ratziu V; Schattenberg JM; Valenti L; Day CP; Cordell HJ; Daly AK; et alii...

2020
AOU Città della Salute di Torino

Caviglia GP; Ciruolo M; Abate ML; Carucci P; Rolle E; Rosso C; Olivero A; Troshina G; Risso A; Nicolosi A; Ribaldone DG; Armandi A; Tandoi F; Saracco GM; Bugianesi E; Ciancio A; Gaia S;

Interplay between Oxidative Stress and Metabolic Derangements in Non-Alcoholic Fatty Liver Disease: The Role of Selenoprotein P. in International journal of molecular sciences / Int J Mol Sci. 2020 Nov 22;21(22):8838. doi: 10.3390/ijms21228838.
2020
AOU Città della Salute di Torino

Caviglia GP; Rosso C; Armandi A; Gaggini M; Carli F; Abate ML; Olivero A; Ribaldone DG; Saracco GM; Gastaldelli A; Bugianesi E;

2020
AOU Città della Salute di Torino

Caviglia GP; Rosso C; Stalla F; Rizzo M; Massano A; Abate ML; Olivero A; Armandi A; Vanni E; Younes R; Fagoonee S; Pellicano R; Astegiano M; Saracco GM; Bugianesi E; Ribaldone DG;

2020
AOU Città della Salute di Torino

Caviglia GP; Tucci A; Pellicano R; Fagoonee S; Rosso C; Abate ML; Olivero A; Armandi A; Vanni E; Saracco GM; Bugianesi E; Astegiano M; Ribaldone DG;

2020
AOU Città della Salute di Torino

Vernero M; De Blasio F; Ribaldone DG; Bugianesi E; Pellicano R; Saracco GM; Astegiano M; Caviglia GP;

Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis. in Science translational medicine / Sci Transl Med. 2020 Dec 2;12(572):eaba4448. doi: 10.1126/scitranslmed.aba4448.
2020
AOU Città della Salute di Torino

Govaere O; Cockell S; Tiniakos D; Queen R; Younes R; Vacca M; Alexander L; Ravaioli F; Palmer J; Petta S; Boursier J; Rosso C; Johnson K; Wonders K; Day CP; Ekstedt M; Oreši? M; Darlay R; Cordell HJ; Marra F; Vidal-Puig A; Bedossa P; Schattenberg JM; Clément K; Allison M; Bugianesi E; Ratziu V; Daly AK; Anstee QM; et alii...

Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease. in The American journal of gastroenterology / Am J Gastroenterol. 2020 Aug;115(8):1289-1292. doi: 10.14309/ajg.0000000000000676.
2020
AOU Città della Salute di Torino

Younes R; Govaere O; Petta S; Miele L; Tiniakos D; Burt A; David E; Vecchio FM; Maggioni M; Cabibi D; Fracanzani AL; Rosso C; Blanco MJG; Armandi A; Caviglia GP; Zaki MYW; Liguori A; Francione P; Pennisi G; Grieco A; Valenti L; Anstee QM; Bugianesi E;

Analytical and clinical evaluation of a novel assay for anti-HBc IgG measurement in serum of subjects with overt and occult HBV infection. in Diagnostic microbiology and infectious disease / Diagn Microbiol Infect Dis. 2020 Apr;96(4):114985. doi: 10.1016/j.diagmicrobio.2020.114985. Epub 202
2020
AOU Città della Salute di Torino

Saracco GM; Romagnoli R; Rizzetto M; Smedile A; Ribaldone DG; Younes R; Abate ML; Rosso C; Troshina G; Tandoi F; Ciancio A; Olivero A; Caviglia GP; Bugianesi E;

Adalimumab Therapy Improves Intestinal Dysbiosis in Crohn's Disease. in Journal of clinical medicine / J Clin Med. 2019 Oct 9;8(10):1646. doi: 10.3390/jcm8101646.
2019
AOU Città della Salute di Torino

Ribaldone DG; Caviglia GP; Abdulle A; Pellicano R; Ditto MC; Morino M; Fusaro E; Saracco GM; Bugianesi E; Astegiano M;

Clinical outcomes in chronic hepatitis C long-term responders to pre-direct antiviral agents: a single-center retrospective study. in Minerva medica / Minerva Med. 2019 Oct;110(5):401-409. doi: 10.23736/S0026-4806.19.06108-1. Epub 2019 May 6.
2019
AOU Città della Salute di Torino

Bugianesi E; Saracco GM; Pellicano R; Rizzetto M; Abate ML; Troshina G; Giordanino C; Olivero A; Younes R; Ciancio A; Ciruolo M; Caviglia GP; Rosso C; Smedile A;

NASH in Lean Individuals. in Seminars in liver disease / Semin Liver Dis. 2019 Feb;39(1):86-95. doi: 10.1055/s-0038-1677517. Epub 2019 Jan 17.
2019
AOU Città della Salute di Torino

Younes R; Bugianesi E;

Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States. in BMC gastroenterology / BMC Gastroenterol. 2019 Apr 16;19(1):56. doi: 10.1186/s12876-019-0972-6.
2019
AOU Città della Salute di Torino

Golabi P; Paik J; Reddy R; Bugianesi E; Trimble G; Younossi ZM;

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. in Nature reviews. Gastroenterology & hepatology / Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):11-20. doi: 10.1038/nrgastro.2017.109. Epub 2017 Sep 2
2018
AOU Città della Salute di Torino

George J; Eslam M; Henry L; Hardy T; Marietti M; Anstee QM; Younossi Z; Bugianesi E;

Should we undertake surveillance for HCC in patients with NAFLD? in Journal of hepatology / J Hepatol. 2018 Feb;68(2):326-334. doi: 10.1016/j.jhep.2017.10.006. Epub 2017 Nov 6.
2018
AOU Città della Salute di Torino

Younes R; Bugianesi E;

Significant improvement of glycemic control in diabetic patients with HCV infection responding to direct-acting antiviral agents. in Journal of medical virology / J Med Virol. 2018 Feb;90(2):320-327. doi: 10.1002/jmv.24954. Epub 2017 Nov 14.
2018
AOU Città della Salute di Torino

Smedile A; Bugianesi E; Ribaldone D; Terzi di Bergamo L; Giordanino C; Gallo M; Bianco Mauthe Degerfeld AGF; Fassio G; Vogliotti E; Sacco M; Pellegrini M; Bosio R; Bo S; Ciancio A; Rizzetto M; Saracco GM;

Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis. in The American journal of gastroenterology / Am J Gastroenterol. 2017 May;112(5):740-751. doi: 10.1038/ajg.2016.453. Epub 2016 Oct 11.
2017
AOU Città della Salute di Torino

Bugianesi E; Burt A; Tiniakos D; Schattenberg JM; Van Gaal L; Francque S; Oliveira CP; Allison M; Romero-Gomez M; Petta S; Dufour JF; Hardy T; McPherson S; Ratziu V; Day CP; Anstee QM;

How to diagnose NAFLD in 2016. in Journal of hepatology / J Hepatol. 2016 Sep;65(3):643-4. doi: 10.1016/j.jhep.2016.05.038. Epub 2016 Jul 9.
2016
AOU Città della Salute di Torino

Bugianesi E; Rosso C; Cortez-Pinto H;

Obesity: Childhood obesity: time bomb for future burden of chronic liver disease. in Nature reviews. Gastroenterology & hepatology / Nat Rev Gastroenterol Hepatol. 2016 Sep;13(9):506-7. doi: 10.1038/nrgastro.2016.120. Epub 2016 Jul 2
2016
AOU Città della Salute di Torino

Marietti M; Bugianesi E;

Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes? in Liver international : official journal of the International Association for the Study of the Liver / Liver Int. 2016 Nov;36(11):1563-1579. doi: 10.1111/liv.13185. Epub 2016 Jun 30.
2016
AOU Città della Salute di Torino

Valenti L; Bugianesi E; Pajvani U; Targher G; Valenti L; Bugianesi E; Pajvani U; Targher G;

Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers. in International journal of molecular sciences / Int J Mol Sci. 2016 May 12;17(5):717. doi: 10.3390/ijms17050717.
2016
AOU Città della Salute di Torino

Sanna C; Rosso C; Marietti M; Bugianesi E;

Progression and Natural History of Nonalcoholic Fatty Liver Disease in Adults. in Clinics in liver disease / Clin Liver Dis. 2016 May;20(2):313-24. doi: 10.1016/j.cld.2015.10.010. Epub 2015 Dec 24.
2016
AOU Città della Salute di Torino

Bugianesi E; Marengo A; Jouness RI;

A "systems medicine" approach to the study of non-alcoholic fatty liver disease. in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver / Dig Liver Dis. 2016 Mar;48(3):333-42. doi: 10.1016/j.dld.2015.10.027. Epub 2015 Nov 14.
2016
AOU Città della Salute di Torino

Bonino F; Bellentani S; Targher G; Bugianesi E; Petta S; Valenti L;

EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: disease mongering or call to action? in Diabetologia / Diabetologia. 2016 Jun;59(6):1145-7. doi: 10.1007/s00125-016-3930-7. Epub 2016 Apr 7.
2016
AOU Città della Salute di Torino

Bugianesi E;

Cytokeratin 18-Aspartate396 apoptotic fragment for fibrosis detection in patients with non-alcoholic fatty liver disease and chronic viral hepatitis. in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver / Dig Liver Dis. 2016 Jan;48(1):55-61. doi: 10.1016/j.dld.2015.09.008. Epub 2015 Sep 28.
2016
AOU Città della Salute di Torino

Smedile A; Bugianesi E; Rizzetto M; Marengo A; Olivero A; Touscoz GA; Mezzabotta L; Vanni E; Abate ML; Rosso C; Caviglia GP;

Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis. in Annual review of medicine / Annu Rev Med. 2016;67:103-17. doi: 10.1146/annurev-med-090514-013832. Epub 2015 Oct 14.
2016
AOU Città della Salute di Torino

Bugianesi E; Rosso C; Marengo A;

Nonalcoholic fatty liver disease. in Nature reviews. Disease primers / Nat Rev Dis Primers. 2015 Dec 17;1:15080. doi: 10.1038/nrdp.2015.80.
2015
AOU Città della Salute di Torino

Brunt EM; Wong VW; Nobili V; Day CP; Sookoian S; Maher JJ; Bugianesi E; Sirlin CB; Neuschwander-Tetri BA; Rinella ME;

Systemic Complications of Nonalcoholic Fatty Liver Disease: When the Liver Is Not an Innocent Bystander. in Seminars in liver disease / Semin Liver Dis. 2015 Aug;35(3):236-49. doi: 10.1055/s-0035-1562944. Epub 2015 Sep 17.
2015
AOU Città della Salute di Torino

Vanni E; Marengo A; Mezzabotta L; Bugianesi E;

Non-invasive score system for fibrosis in chronic hepatitis: proposal for a model based on biochemical, FibroScan and ultrasound data. in Liver international : official journal of the International Association for the Study of the Liver / Liver Int. 2015 Aug;35(8):2027-35. doi: 10.1111/liv.12761. Epub 2015 Jan 21.
2015
AOU Città della Salute di Torino

Gaia S; Campion D; Evangelista A; Spandre M; Cosso L; Brunello F; Ciccone G; Bugianesi E; Rizzetto M;